logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Rongrui Liu

Chinese PLA General Hospital
H指数:14
被引数:1,212

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors

M701的开发与临床试验：一种靶向性腹腔内治疗，用于治疗源于晚期实体瘤的恶性腹水（抗EpCAM × 抗CD3双特异性抗体）

Experimental Hematology & Oncology
IF13.5
2025-11-230
OAAI
Rongrui Liu; Rongbo Lin; Ning Li; Guiling Li; Tao Zhang; Jun Zhao; Jiayi Li; Meili Sun; Ke Wang; Hanxiang An; Weijie Zhang; Huiting Xu; Shan Zeng; Mingjun Zhang; Wei Duan; Yuxian Bai; Jingdong Zhang; He Tian; Fei Yin; Yu Kang; Qi Xu; Nong Xu; Yanhong Deng; Qing Chen; Yongqiang Li; Hongying Yang; Fang Su; Zhenghong Xiao; Xiaojun Xiang; Pengfei Zhou; Shaoyi Huang; Jing Zhang; Jianming Xu
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study

TROP-2靶向抗体药物偶联物SHR-A1921治疗晚期或转移性实体瘤：一项首次人体1期研究

Cancer Cell
IF44.5
2025-10-230
PRE
Jia Zhong; Lin Wu; Zhengbo Song; Nianzeng Xing; Jiujie Cui; Xingya Li; Kailun Fei; Dihong Tang; Qi Dang; Liang Chen; Tianshu Liu; Caigang Liu; Yong Li; Shichuan Zhang; Xinghua Han; Juxiang Xiao; Feng Guo; Min Yan; Huiting Xu; Chunxiu Yuan; Jincai Zhong; Rongrui Liu; Xiujuan Qu; Shikai Wu; Shusuan Jiang; Yan Yang; Panpan Zhang; Hongqian Guo; Ce Wang; Qiushi Xie; Zhifei Lin; Shuni Wang; Jie Wang
A140 plus mFOLFOX6 compared with cetuximab plus mFOLFOX6 for first-line RAS wild-type metastatic colorectal cancer: A randomized clinical trial

A140 plus mFOLFOX6与cetuximab plus mFOLFOX6对比治疗一线RAS野生型转移性结直肠癌：一项随机临床试验

European Journal of Cancer
IF7.1
2025-06-070
PRE
Rongrui Liu; Xianli Yin; Yuxian Bai; Haijun Zhong; Feng Ye; Qi Wang; Mulin Liu; Ning Li; Yanhong Deng; Yusheng Wang; Jinxiu Xu; Wei Li; Kehe Chen; Sanjun Cai; Jianwei Yang; Tao Zhang; Yunfeng Li; Baoli Qin; Lichun Deng; Shulin Liu; Jianming Xu
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors

PARP抑制剂氟唑帕利 (SHR3162) 在晚期实体瘤患者中的I期剂量递增和扩展研究

CHINESE JOURNAL OF CANCER RESEARCH
IF6.3
2020-01-0123
OA
Li, Huiping; Liu, Rongrui; Shao, Bin; Ran, Ran; Song, Guohong; Wang, Ke; Shi, Yehui; Liu, Jihong; Hu, Wenjing; Chen, Fu; Liu, Xiaoran; Zhang, Gairong; Zhao, Chuanhua; Jia, Ru; Wang, Quanren; Rugo, Hope S.; Zhang, Yifan; Li, Guangze; Xu, Jianming
DNA in serum extracellular vesicles is stable under different storage conditions

血清细胞外囊泡中的DNA在不同储存条件下是稳定的

BMC CANCER
IF3.4
2016-09-23121
OAAI
Jin, Yang; Chen, Keyan; Wang, Zongying; Wang, Yan; Liu, Jianzhi; Lin, Li; Shao, Yong; Gao, Lihua; Yin, Huihui; Cui, Cong; Tan, Zhaoli; Liu, Liejun; Zhao, Chuanhua; Zhang, Gairong; Jia, Ru; Du, Lijuan; Chen, Yuling; Liu, Rongrui; Xu, Jianming; Hu, Xianwen; Wang, Youliang

研究方向

暂未获取到该数据
J
Jianming Xu
H 指数:56论文数:387被引数:2.6万
C
Chuanhua Zhao
H 指数:15论文数:74被引数:801
Y
Yuxian Bai
H 指数:59论文数:366被引数:1.9万
X
Xiaojun Xiang
H 指数:33论文数:143被引数:2,828
J
Juan Li
H 指数:28论文数:323被引数:3,263
H
Huiting Xu
H 指数:7论文数:37被引数:228
R
Ru Jia
H 指数:19论文数:74被引数:1,161
N
Nong Xu
H 指数:21论文数:125被引数:2,074
Y
Yan Wang
H 指数:48论文数:483被引数:8,277
Y
Yanhong Deng
H 指数:48论文数:623被引数:9,766